Annovis Bio, Inc. (ANVS) KPIs and segments

ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30

$0.93+0.08 (+9.31%)

Close on Nov 13, 2026Market cap $39.46MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Annovis Bio's business

Coming soon

This tab will track the numbers specific to Annovis Bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?